A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts

Haematologica

Volumn 90, Issue 5, 2005, Pages 715-716

  Jun, Huang Xiao ^a   Jun, Chang Ying ^a   Yu, Zhao Xiang ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Bone marrow grafts; Costimulatory molecules; Dendritic cells; G CSF; Peripheral blood stem cell grafts; T cells

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CYTOKINE PRODUCTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOCOMPETENT CELL; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STEM CELL MOBILIZATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL COUNT; CLONAL ANERGY; CYTOKINES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TH1 CELLS; TH2 CELLS;

EID: 20344396399     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Morton J, Hutchins H, Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow:significiantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001;98:3186-91.
2. Elfenbein GJ, Sackatein R. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. Bone Marrow Transplant 2004;32:327-39.
3. Chen SH, Li X, Huang XJ. Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect. Int J Hematol 2004:79:178-84.
4. Huang XJ, Chang YJ, Zhao XY. In vivo induction of T cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using a granulocyte colony-stimulating factor. Haematologica 2004;89:1517-24.
5. Krenger W, Ferrara JLM. Graft-versus-host disease and the Th1/Th2 paradigm. Immuno Res 1996;15:50-73.
6. Fowler DH, Breglio J, Nagel G, Hirose C, Gress RE. Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II abrogate GVL. Biol Blood Marrow Transplant 1996;3:118-25.
7. Jung U, Foley JE, Erdmann AA, Eckhaus MA, Fowler DH. CD3/CD28- costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVL and GVHD effects. Blood 2003;102:3439-46.
8. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH. Differential ability of Th1 and Th2 cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1994;6:1545-53.
9. Klangsinsirikul P, Russell NH. Peripheral blood stem cell harvest from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 2002;30:495-501.
10. Harding FA, McArthur JG, Gross JA, Raulet DH, Alliaon JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-9.